136 related articles for article (PubMed ID: 29190698)
1. Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2'-deoxycytidine level in cultured cancerous cell lines.
Foksinski M; Zarakowska E; Gackowski D; Skonieczna M; Gajda K; Hudy D; Szpila A; Bialkowski K; Starczak M; Labejszo A; Czyz J; Rzeszowska-Wolny J; Olinski R
PLoS One; 2017; 12(11):e0188856. PubMed ID: 29190698
[TBL] [Abstract][Full Text] [Related]
2. Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships.
Gackowski D; Zarakowska E; Starczak M; Modrzejewska M; Olinski R
PLoS One; 2015; 10(12):e0144859. PubMed ID: 26660343
[TBL] [Abstract][Full Text] [Related]
3. Accurate, Direct, and High-Throughput Analyses of a Broad Spectrum of Endogenously Generated DNA Base Modifications with Isotope-Dilution Two-Dimensional Ultraperformance Liquid Chromatography with Tandem Mass Spectrometry: Possible Clinical Implication.
Gackowski D; Starczak M; Zarakowska E; Modrzejewska M; Szpila A; Banaszkiewicz Z; Olinski R
Anal Chem; 2016 Dec; 88(24):12128-12136. PubMed ID: 28193047
[TBL] [Abstract][Full Text] [Related]
4. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease.
Dziaman T; Gackowski D; Guz J; Linowiecka K; Bodnar M; Starczak M; Zarakowska E; Modrzejewska M; Szpila A; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Marszalek A; Olinski R
Clin Epigenetics; 2018; 10():72. PubMed ID: 29875879
[TBL] [Abstract][Full Text] [Related]
5. Quantification of DNA Modifications Using Two-Dimensional Ultraperformance Liquid Chromatography Tandem Mass Spectrometry (2D-UPLC-MS/MS).
Starczak M; Gawronski M; Olinski R; Gackowski D
Methods Mol Biol; 2021; 2198():91-108. PubMed ID: 32822025
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the absolute level of epigenetic marks 5-methylcytosine, 5-hydroxymethylcytosine, and 5-hydroxymethyluracil between human leukocytes and sperm.
Guz J; Gackowski D; Foksinski M; Rozalski R; Olinski R
Biol Reprod; 2014 Sep; 91(3):55. PubMed ID: 25061097
[TBL] [Abstract][Full Text] [Related]
7. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract][Full Text] [Related]
8. Urinary Measurement of Epigenetic DNA Modifications: A Non-Invasive Assessment of the Whole-Body Epigenetic Status in Healthy Subjects and Colorectal Cancer Patients.
Rozalski R; Gackowski D; Siomek-Gorecka A; Banaszkiewicz Z; Olinski R
ChemistryOpen; 2016 Dec; 5(6):550-553. PubMed ID: 28032024
[TBL] [Abstract][Full Text] [Related]
9. Oxidation Products of 5-Methylcytosine are Decreased in Senescent Cells and Tissues of Progeroid Mice.
Zarakowska E; Czerwinska J; Tupalska A; Yousefzadeh MJ; Gregg SQ; Croix CMS; Niedernhofer LJ; Foksinski M; Gackowski D; Szpila A; Starczak M; Tudek B; Olinski R
J Gerontol A Biol Sci Med Sci; 2018 Jul; 73(8):1003-1009. PubMed ID: 29415265
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA.
Liu S; Wang J; Su Y; Guerrero C; Zeng Y; Mitra D; Brooks PJ; Fisher DE; Song H; Wang Y
Nucleic Acids Res; 2013 Jul; 41(13):6421-9. PubMed ID: 23658232
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
Skalska-Bugala A; Starczak M; Szukalski Ł; Gawronski M; Siomek-Gorecka A; Szpotan J; Labejszo A; Zarakowska E; Szpila A; Jachalska A; Szukalska A; Kruszewski M; Sadowska A; Wasilow A; Baginska P; Czyz J; Olinski R; Rozalski R; Gackowski D
Cells; 2022 Mar; 11(5):. PubMed ID: 35269510
[TBL] [Abstract][Full Text] [Related]
12. Detection of oxidation products of 5-methyl-2'-deoxycytidine in Arabidopsis DNA.
Liu S; Dunwell TL; Pfeifer GP; Dunwell JM; Ullah I; Wang Y
PLoS One; 2013; 8(12):e84620. PubMed ID: 24391970
[TBL] [Abstract][Full Text] [Related]
13. Urinary Measurement of Epigenetic DNA Modifications and 8-oxodG as Possible Noninvasive Markers of Colon Cancer Evolution.
Skalska-Bugala A; Siomek-Gorecka A; Banaszkiewicz Z; Olinski R; Rozalski R
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430302
[TBL] [Abstract][Full Text] [Related]
14. Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase.
Bhattacharya C; Dey AS; Ayon NJ; Gutheil WG; Mukherji M
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371677
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease.
Starczak M; Zarakowska E; Modrzejewska M; Dziaman T; Szpila A; Linowiecka K; Guz J; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Gackowski D; Olinski R
J Transl Med; 2018 Jul; 16(1):204. PubMed ID: 30029654
[TBL] [Abstract][Full Text] [Related]
16. Preparation of Internal Standards for 2D-UPLC-MS/MS Quantification of Noncanonical DNA Bases.
Starczak M; Skalska A; Rozalski R; Olinski R; Gackowski D
Methods Mol Biol; 2021; 2198():123-136. PubMed ID: 32822027
[TBL] [Abstract][Full Text] [Related]
17. A validated quantitative liquid chromatography-tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA.
Tsuji M; Matsunaga H; Jinno D; Tsukamoto H; Suzuki N; Tomioka Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():38-47. PubMed ID: 24568937
[TBL] [Abstract][Full Text] [Related]
18. Correction: Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2'-deoxycytidine level in cultured cancerous cell lines.
Foksinski M; Zarakowska E; Gackowski D; Skonieczna M; Gajda K; Hudy D; Szpila A; Bialkowski K; Starczak M; Labejszo A; Czyz J; Rzeszowska-Wolny J; Olinski R
PLoS One; 2018; 13(4):e0195819. PubMed ID: 29630664
[TBL] [Abstract][Full Text] [Related]
19. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis.
Tang Y; Zheng SJ; Qi CB; Feng YQ; Yuan BF
Anal Chem; 2015 Mar; 87(6):3445-52. PubMed ID: 25675106
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a DNA promoter segment containing all four epigenetic nucleosides: 5-methyl-, 5-hydroxymethyl-, 5-formyl-, and 5-carboxy-2'-deoxycytidine.
Schröder AS; Steinbacher J; Steigenberger B; Gnerlich FA; Schiesser S; Pfaffeneder T; Carell T
Angew Chem Int Ed Engl; 2014 Jan; 53(1):315-8. PubMed ID: 24281791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
